Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 3,324 shares at $16.03 ($53K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Seasonal sale ($53k) by Chief Operating Officer — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.03 | 2,107 | $34K | 63.4% |
| 2 | $16.01 | 1,217 | $19K | 36.6% |
| Total | $16.02 avg | 3,324 | $53K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $330K | — | Filing → |